Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence

MLA

Orit Cohen-Barak, et al. “Placebo-Controlled Evaluation of a Bioengineered, Cocaine-Metabolizing Fusion Protein, TV-1380 (AlbuBChE), in the Treatment of Cocaine Dependence.” Drug and Alcohol Dependence, pp. 13–20. EBSCOhost, https://doi.org/10.1016/j.drugalcdep.2016.05.019. Accessed 24 Feb. 2025.

APA

Orit Cohen-Barak, Rom E. Eliaz, Nora Chiang, David J. McCann, Yossi Gilgun-Sherki, Pippa S. Loupe, Hussein Hallak, Eli Eyal, Kathleen Blatt, & Shwe Gyaw. (n.d.). Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence. Drug and Alcohol Dependence, 13–20. https://doi.org/10.1016/j.drugalcdep.2016.05.019

Chicago

Orit Cohen-Barak, Rom E. Eliaz, Nora Chiang, David J. McCann, Yossi Gilgun-Sherki, Pippa S. Loupe, Hussein Hallak, Eli Eyal, Kathleen Blatt, and Shwe Gyaw. 2025. “Placebo-Controlled Evaluation of a Bioengineered, Cocaine-Metabolizing Fusion Protein, TV-1380 (AlbuBChE), in the Treatment of Cocaine Dependence.” Drug and Alcohol Dependence, 13–20. Accessed February 24. doi:10.1016/j.drugalcdep.2016.05.019.